Total Revenue and Adjusted EBITDA1,2 above high end of previously provided guidanceTotal End of Period Subscribers of 2.8 million; End of ...
Total Revenue and Adjusted EBITDA1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% year-over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results